Intas Pharmaceuticals, Ltd. et al. v. Atossa Therapeutics, Inc.

IPR2025-00799

Intas Pharmaceuticals successfully secured the institution of IPR against Atossa Therapeutics over a drug polymorph patent (11,261,151), challenging claims based on anticipation and obviousness using prior art Liu.

Jurisdiction
US PTAB
Case Number
IPR2025-00799
Filing Date
4 March 2025
Outcome
instituted

Practitioner Note

This case demonstrates the evidentiary and procedural standards applied in patent matters before local courts. Understanding the court's reasoning in Intas Pharmaceuticals, Ltd. et al. vs Atossa Therapeutics, Inc. is valuable context for structuring arguments or assessing risk in similar proceedings.

Related Cases

patentIPR2024-00270

CISCO SYSTEMS, INC.vsUMBRA TECHNOLOGIES LTD.

CISCO SYSTEMS, INC. successfully petitioned the PTAB to institute an IPR against UMBRA TECHNOLOGIES LTD.'s patent 11108595. The Board found the petition particularly strong on the merits and favorable regarding Fintiv factors.

patentIPR2024-00436

Comcast Corporation et al.vsEntropic Communications LLC

Comcast Cable Communications challenged Entropic's patent (11,381,866) in an IPR proceeding, asserting that the claims are obvious over various combinations of prior art. The petitioner relies heavily on combining Cholas and Petrovic with references like Rabaey, Maalej, Lee, and Takahiko to demonstrate non-patentability under 35 U.S.C. § 103.

patentIPR2024-01239

Arista Networks, Inc.vsOrckit Corporation

Arista Networks challenges Orckit Corporation's patent (10652111) in an IPR, asserting that the claimed Deep Packet Inspection functionality within a Software Defined Networking controller is obvious.

patentIPR2024-00947

Siemens Mobility, Inc. et al.vsMetrom Rail, LLC

Siemens Mobility's IPR challenge against Metrom Rail's rail vehicle control patent was denied by the PTAB. The Board found that the arguments presented were substantially similar to those previously raised during prosecution, leading to a discretionary denial under 35 U.S.C. § 325(d).

patentIPR2024-00802

ELMOS SEMICONDUCTOR SEvsTexas Instruments Incorporated

ELMOS SEMICONDUCTOR SE's IPR challenge against Texas Instruments Incorporated was denied by the PTAB, as the petitioner failed to demonstrate a reasonable likelihood of prevailing. The Board found that ELMOS lacked adequate motivation and particularity in its obviousness arguments across multiple grounds.

Arctic Invent — IP Strategy

Dealing with a patent challenge?

Whether it's a Section 3(d) rejection, a post-grant opposition, or a FRAND dispute, Arctic's patent litigation team has handled it. Get a strategy call.

Talk to our patent team →

Disclaimer: This page contains an automated summary based on publicly available judicial records. The content is generated for informational purposes only and does not constitute legal advice. Always verify details against the original source judgment before relying on this information for any legal purpose. If you believe any information is inaccurate, please contact us.

Strategy Consult

Facing a similar patent matter?

Arctic's litigation team uses precedent data like this to build winning arguments.

Get a Strategy Call